Newsletter | July 10, 2024

07.10.24 -- Where's The Case For Generative AI In Biopharmaceutical Manufacturing?

SPONSOR

Complex protein-based therapies don’t play by the same process-engineering rules as small molecules and traditional biologics. They require developers to see the unforeseen and embrace new roles and responsibilities in sourcing raw materials and outsourced expertise. Successful developers can’t let this winding road slow their time to IND. Join Bioprocess Online Live on August 8th for an interactive discussion on early workflow considerations for complex protein-based therapeutics. Supported by Thermo Fisher Scientific.

FOCUS ON DOWNSTREAM MANUFACTURING

Where's The Case For Generative AI In Biopharmaceutical Manufacturing?

The early use cases for AI in the biopharmaceutical industry — at least, the early public use cases — have largely come from R&D, and more specifically, target identification and molecular design. Where are the use cases in biologics manufacturing, supply chain management, QMS, and operations, and what’s holding us back?

The Future Of Biopharmaceuticals: Top Trends And Risks

Explore six trends and risks currently paving the way to the future of biopharmaceutical manufacturing.

Understanding Sedimentation Velocity Analytical Ultracentrifugation

A recent webinar discussing the use of SV-AUC to characterize and quantify AAV species also featured a Q&A with presenter N. Karl Maluf, Ph.D.

Gradient Performance Of A Single-Use Chromatography System

Explore a single-use chromatography system that introduces micro-efficiencies into the manufacturing workflow process, potentially leading to time and cost savings throughout the production life cycle.

Developing A Large-Scale Tangential Flow Filtration Process

Discover a process that can be modified to fit your downstream process and serves as a complete solution for concentration and diafiltration.

The Coevolution Of The Single-Use And Biopharmaceutical Industries

Learn more about the evolution of one company's solutions for biopharmaceutical manufacturing and accelerating market entrance using single-use technology.

SPONSOR

Webinar: Speed up process development with HTS tools for affinity chromatography for newer modalities: Case Studies for AAV, mRNA, and plasma feeds

HTS is not a common approach for new modalities, such as messenger mRNA, rAAV, and plasma-derived products. Join us on July 16th to learn how to speed up process development with GoPure™ 96-well high throughput screening plates pre-filled with various affinity resins for newer therapeutic modalities.

DOWNSTREAM MANUFACTURING SOLUTIONS

Be A Gain Changer, 2x Throughput, Only With Supor Prime - Cytiva

Improve Purification Performance And Lower The Cost Per Gram - Purolite, An Ecolab Company

Advanced Magnetic Bead Technology For DNA Purification - Thermo Fisher Scientific

SPONSOR

Bioprocess Online is excited to introduce Bio-Expo Live, a series of live virtual events designed to empower biopharma professionals with the chance to conveniently explore the newest equipment and offerings in Upstream Bioprocessing, Downstream Bioprocessing and Bioprocess Quality, Data, and Analytical Solutions. Registration is free, reserve your spot today!

Connect With Bioprocess Online: